N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-methylsulfanyl-1,2,5-oxadiazole-3-carboximidamide
C10H8BrFN4O2S — CID 138737927
Data last refreshed: (MolForge compound catalog, from PubChem)
About N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-methylsulfanyl-1,2,5-oxadiazole-3-carboximidamide
N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-methylsulfanyl-1,2,5-oxadiazole-3-carboximidamide (PubChem CID 138737927) has the molecular formula C10H8BrFN4O2S and a molecular weight of 347.17 g/mol. Its IUPAC name is N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-methylsulfanyl-1,2,5-oxadiazole-3-carboximidamide.
Molecular Properties
| Compound Name | N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-methylsulfanyl-1,2,5-oxadiazole-3-carboximidamide |
|---|---|
| PubChem CID | 138737927 |
| Molecular Formula | C10H8BrFN4O2S |
| Molecular Weight | 347.17 g/mol |
| Exact Mass | 345.95 |
| IUPAC Name | N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-methylsulfanyl-1,2,5-oxadiazole-3-carboximidamide |
| SMILES | CSc1nonc1/C(=N/c1ccc(F)c(Br)c1)NO |
| InChI | InChI=1S/C10H8BrFN4O2S/c1-19-10-8(15-18-16-10)9(14-17)13-5-2-3-7(12)6(11)4-5/h2-4,17H,1H3,(H,13,14) |
| InChIKey | AIQMUSBBSCOYQK-UHFFFAOYSA-N |
| XLogP | 2.75 |
| TPSA | 83.54 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 347.17 |
| LogP ≤ 5 | 2.75 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138737927 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.